Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea
NCT ID: NCT07277608
Last Updated: 2025-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2023-08-07
2033-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010
Role of Biomarkers to Screen for Obstructive Sleep Apnea
NCT04093102
The Impact of Sleep Apnea Treatment on Physiology Traits in Chinese Patients With Obstructive Sleep Apnea
NCT02696629
A Simplified Questionnaire to Detect OSA in COPD Patients
NCT01801761
Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment
NCT01976052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe OSA
No interventions assigned to this group
Non-severe OSA
No interventions assigned to this group
Healthy controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.
Exclusion Criteria
* Pregnant or lactating women;
* Patients with severe respiratory failure requiring mechanical ventilation;
* Patients with severe heart, lung, liver, kidney, and central nervous system damage;
* Refuse to participate in follow-up visits and/or take biological samples.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhaohui Tong
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Chaoyang hospital affiliated to Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-ke-450
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.